Work

The ORMDL3-ceramide axis may be a novel therapeutic target for the control of allergic airway disease

Year: 2016

Type: conference-abstract

Source: The Journal of Immunology

DOI: 10.4049/jimmunol.196.supp.192.24

Authors: Jamie L Sturgill, Daniel H Conrad, Clement Oyeniran, Sarah Spiegel

Institution: Virginia Commonwealth University

Language: English

Topic: Asthma and respiratory diseases

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2745135388

Cites:

Cited by:

Related to: 10